2022
DOI: 10.1080/13816810.2022.2034168
|View full text |Cite
|
Sign up to set email alerts
|

Bilateral recurrent pseudodendritic keratopathy as the initial manifestation of tyrosinemia type II

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…HTI, the most clinically challenging of these disorders, is caused by mutations in the gene fumarylacetoacetate hydrolase (FAH) leading to the accumulation of toxic metabolites causing apoptosis and liver and renal failure [1,2]. HTII, tyrosine aminotransferase deficiency, causes oculocutaneous and hyperkeratosis of the feet and hands [3,4]. HTIII, the rarest of the HTs, has a variable neurological outcome that is inadequately defined [5,6].…”
Section: Introductionmentioning
confidence: 99%
“…HTI, the most clinically challenging of these disorders, is caused by mutations in the gene fumarylacetoacetate hydrolase (FAH) leading to the accumulation of toxic metabolites causing apoptosis and liver and renal failure [1,2]. HTII, tyrosine aminotransferase deficiency, causes oculocutaneous and hyperkeratosis of the feet and hands [3,4]. HTIII, the rarest of the HTs, has a variable neurological outcome that is inadequately defined [5,6].…”
Section: Introductionmentioning
confidence: 99%